20/05/2026
Today on International Clinical Trials Day, we’re proud to highlight research that’s helping shape the future of treatment for Ewing sarcoma patients.
With a Clinical Trial Support Grant from the Bone Cancer Research Trust, Professor Bernadette Brennan from Manchester University NHS Foundation Trust , Royal Manchester Children’s Hospital is leading a study within the INTER-EWING-1 clinical trial, in collaboration with Professor Hans Merks, Prinses Máxima Centrum voor kinderoncologie and Mr Piers Gaunt, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham.
Together, they are testing if an advanced whole-body imaging technique is better at detecting bone metastases in Ewing sarcoma than PET/CT scans.
“Accurately detecting whether Ewing sarcoma has spread to other bones is critical in guiding treatment decisions and improving outcomes for patients. This study will help us understand whether this advanced whole-body imaging approach can identify metastases more effectively and monitor how they respond to treatment.” - Professor Bernadette Brennan
This research is a vital step towards giving clinicians a clearer, more accurate picture of the disease and ensuring patients receive the right treatment at the right time.
Read more: https://ow.ly/SJqT50Z279G